Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serial Amnioinfusions for Fetal Pulmonary Hypoplasia
NCT03723564Phase 1Recruiting
- Sponsor
- Mayo Clinic
- Start
- Oct 2018
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of lactated ringer's solution in pulmonary hypoplasia, sponsored by Mayo Clinic. Primary endpoint: Adverse Events up to 22 weeks. Started Oct 2018; status: recruiting.
02
Drugs
lactated ringer's solution
03
Conditions
pulmonary hypoplasia
Beyond the preview
Go deeper on NCT03723564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03723564.